Φορτώνει......
Early presentation of pembrolizumab-associated pneumonitis
Pembrolizumab is a selective anti-PD-L1 humanised monoclonal antibody approved by the Food and Drug Administration for treating multiple cancers, including cervical cancer, non-small cell lung cancer (NSCLC), renal cell carcinoma, bladder cancer, and squamous head and neck cancer. Pneumonitis is a r...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | BMJ Case Rep |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMJ Publishing Group
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8286739/ https://ncbi.nlm.nih.gov/pubmed/34266820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2021-242493 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|